Here’s what you need to know.
1. In 2015, the market accounted for $5.6 billion and it’s expected to reach $8.5 billion by 2021. The market’s CAGR projects to be 7 percent between 2016 and 2021.
2. Gastrointestinal endoscopic devices are in high demand because of an increase in GI disorders.
3. That demand could slow because of fear over high infection rates in endoscopes and a decreasing reimbursement base.
4. GI videoscopes were the key market player in 2015, but Zion expects capsule endoscopes to challenge that market share.
5. North America is the manufacturing leader with a more than 30 percent market share. The Asian Pacific market projects to be the fastest growing in the coming years,
More articles on gastroenterology/endoscopy:
AGA, NACCME develop 3 regional educational programs about IBD: 3 notes
Boston Scientific acquires LumenR Tissue Retractor System; Takeda, Koneksa Health to introduce wearable technology for clinical studies & more: 6 GI company key notes
11 private endoscopy clinics in Montreal to close after losing accessory fees: 5 key notes
